Instagram Ern-EyeFacebook Ern-EyeTwitter Ern-EyeLinkedIn Ern-EyeYouTube Ern-EyeHow to use the speech recognition tool?
2020-004594-43
AUDIOWOLF
A phase II, open-label, efficacy study of daily administration of sodium valproate in patients clinically affected by Wolfram syndrome due to monogenic mutation.
Type: Interventional
Status of the trial: Active, Recruiting
Orphan Drug Recognition: No
Inclusion
- Opening Date: 2019-03-26
- Closing Date: 2021-08-31
Criteria
Children: Yes
Adults: Yes
Funder Type: public
HCP: Principal investigators
HCP: Other investigators
Within ERN-EYE members
Workgroups
Neuro-Ophthalmology Rare Diseases (WG2)
This ERN is supported by:
